PAVmed Inc. (PAVM) — Institutional Holders, Q2 2026

20 institutional investment managers reported a PAVM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $5.6M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

PAVM in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

5

Added to

6

Trimmed

3

Sold out

4

Biggest buyers

  1. FIRST MANHATTANAdded · +309,106 sh+$1.8M
  2. VANGUARD CAPITAL MANAGEMENTAdded · +55,687 sh+$330.8K
  3. GEODE CAPITAL MANAGEMENTAdded · +24,901 sh+$147.9K
  4. VANGUARD FIDUCIARYAdded · +20,176 sh+$119.8K
  5. BlackRockAdded · +14,676 sh+$87.2K

Biggest sellers

  1. Tower Research Capital (TRC)Sold out · -622 sh-$3.7K
  2. Vanguard Global AdvisersSold out · -61 sh-$362.00
  3. UBS Group AGTrimmed · -18 sh-$107.00
  4. MORGAN STANLEYTrimmed · -2 sh-$12.00
  5. GROUP ONE TRADING, L.P.Sold out · -2 sh-$12.00

PAVM 13F holders ranked 1–20 of 20

Institutional investors reporting a position in PAVmed Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Two Seas Capital#1 · 461,539 sh$2.7M0.0%
FIRST MANHATTAN#2 · 332,911 sh$2.0M+1298.5%
VANGUARD CAPITAL MANAGEMENT#3 · 61,604 sh$365.9K+941.1%
GEODE CAPITAL MANAGEMENT#4 · 36,678 sh$217.9K+211.4%
VANGUARD FIDUCIARY#5 · 25,605 sh$152.1K+371.6%
BlackRock#6 · 17,092 sh$101.5K+607.5%
MORGAN STANLEY#7 · 163 sh$968.00-1.2%
BARCLAYS PLC#8 · 75 sh$446.00New
SBI Securities , Ltd.#9 · 67 sh$398.000.0%
UBS Group AG#10 · 57 sh$339.00-24.0%
WELLS FARGO & COMPANY#11 · 45 sh$267.000.0%
Integrated Wealth Concepts#12 · 13 sh$78.00New
Allworth Financial#13 · 5 sh$30.00-16.7%
Federation des caisses Desjardins du Quebec#14 · 4 sh$23.00New
OSAIC#15 · 4 sh$21.000.0%
Steward Partners Investment Advisory#16 · 2 sh$12.00+100.0%
BNP PARIBAS FINANCIAL MARKETS#17 · 1 sh$6.000.0%
Caitong International Asset Management , Ltd#18 · 1 sh$6.00New
JONES FINANCIAL COMPANIES LLLP#19 · 1 sh$5.000.0%
ROYAL BANK OF CANADA#20 · 1 sh$0.00New

Funds that sold out of PAVM in Q2 2026 (4)

Held PAVM at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held PAVM in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Tower Research Capital (TRC)622 sh$6.3K
Vanguard Global Advisers61 sh$619.00
GROUP ONE TRADING, L.P.2 sh$20.00
AdvisorNet Financial1 sh$10.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.